CREST Syndrome: Symptoms, Causes & Treatment

Most medical conditions make their presence known. CREST disease isn't like that. It sneaks in quietly, sometimes starting with nothing more alarming than fingers that go numb in cold weather. It can take years, even decades, to fully show. For most patients, by the time they finally get a diagnosis, the condition has already been along for the ride for quite a while.

CREST disease is a rare autoimmune disorder, affecting roughly 1 in 10,000 people. CREST falls under the umbrella of systemic sclerosis (also called scleroderma), and it's specifically the limited cutaneous form. Its effects tend to stay concentrated in the skin of the hands, face, and feet, rather than spreading more broadly through the body. The name itself is an acronym, each letter standing for one of its five hallmark features: Calcinosis, Raynaud's phenomenon, Esophageal dysfunction, Sclerodactyly, and Telangiectasia.

Women are diagnosed anywhere from four to twelve times more often than men, and it most commonly surfaces between the ages of 30 and 60. There's no cure, but catching it early makes a real difference. It can slow how the condition progresses, head off some of the more serious complications, and give patients a much better shot at living a full, well-managed life.

What Is CREST Syndrome?

CREST Syndrome falls under the umbrella of limited cutaneous systemic sclerosis (lcSSc), an autoimmune condition where the immune system essentially turns on the body's own connective tissue. The result is a collagen overproduction that damages blood vessels and causes progressive scarring of the skin, and sometimes the internal organs, too.

Compare it to diffuse scleroderma, which hits major organs within months, and CREST looks very different. It moves slowly, often over decades, and the skin involvement tends to stay put around the fingers, hands, and face. The ten-year survival rate is over 85%, versus roughly 65% for diffuse scleroderma. Most patients also test positive for the anti-centromere antibody (ACA), which shows up in 60 to 90% of cases and serves as a key diagnostic marker.

Symptoms of CREST Syndrome

Symptoms develop gradually and vary widely between patients. The most commonly reported include:

• Cold-triggered colour changes in fingers and toes: white, then blue, then red, often the very first sign
• Puffy or swollen fingers, particularly in the early stages
• Skin tightening and shining on the fingers, hands, and face
• Chronic heartburn, acid reflux, or difficulty swallowing
• Hard, tender lumps under the skin at pressure points like fingers and elbows
• Visible red spots on the face, lips, and hands
• Joint pain and stiffness
• Persistent fatigue and muscle weakness
• Digital ulcers are open sores on fingertips in advanced cases
• Shortness of breath or a dry cough if lung involvement develops

What Does CREST Stand For? The Five Features Explained

Each letter in CREST points to a distinct clinical feature, and together, they form the complete picture of this condition.

C: Calcinosis

Calcinosis is what happens when calcium deposits build up abnormally beneath the skin or in soft tissue. They form hard, tender lumps most often on the fingers, elbows, and other pressure points. They hurt. And if they break through the skin surface, they leave open wounds that are prime targets for infection. On X-rays, the pattern is striking enough that it's sometimes called "snowstorm" deposits. Calcinosis affects somewhere between 10 and 40% of CREST patients.

 R: Raynaud's Phenomenon

This one's the most common feature, present in around 95% of patients. When fingers and toes are exposed to cold or even emotional stress, the blood vessels overreact by clamping down in a vasospasm that cuts off circulation. The color sequence is pretty distinctive: fingers go white first as blood flow stops, then blue as oxygen depletes, then red and painful as circulation finally rushes back. Without treatment, about 40% of patients end up with digital ulcers. For many people, this happens every single day.

E: Esophageal Dysfunction

In 80 to 90% of CREST patients, the smooth muscle of the esophagus gradually weakens, throwing off normal swallowing and digestion. This typically shows up as GERD, difficulty swallowing, chronic heartburn, and regurgitation. If the reflux goes untreated long-term, the risk of developing Barrett's esophagus climbs tenfold. In some cases, the dysfunction spreads further into the small bowel, leading to bloating and malabsorption.

S: Sclerodactyly

Affecting roughly 95% of patients, sclerodactyly is the thickening and tightening of skin on the fingers and hands. It takes on a shiny, taut, almost bound-down look and loses its normal flexibility. Over time, finger contractures can set in and seriously limit how well the hands function. Pitted scars from healed digital ulcers are common, too. A technique called nailfold capillaroscopy, which looks at the tiny blood vessels at the base of the nail, typically reveals abnormal patterns in affected patients.

T: Telangiectasia

These are small, mat-like clusters of dilated blood vessels sitting just under the skin. They show up as red spots on the face, lips, hands, and sometimes inside the mouth. Present in 60 to 80% of patients, they're usually painless, though they can bleed, especially on mucous membranes. They're mostly a cosmetic concern, but they do point to something deeper: the underlying vascular fragility that's characteristic of CREST Syndrome as a whole.

Who Is at Risk?

CREST disease does not affect everyone equally; certain groups carry a significantly higher chance of developing the condition.

• Women are affected four to twelve times more than men
• Peak diagnosis age is between 40 and 50
• Higher prevalence among the US white populations and certain Native American groups (Choctaw)
• People with other autoimmune conditions, such as primary biliary cholangitis (40%), Sjögren's syndrome (30%), rheumatoid arthritis, or lupus, carry a higher risk
• Occupational exposure in miners and painters increases risk nearly threefold

How Is CREST Syndrome Diagnosed?

Diagnosis follows the ACR/EULAR 2013 criteria and requires a combination of clinical findings, antibody testing, and specialist investigations; no single test confirms it alone.

Physical Examination 

Doctors look for three or more of the five CREST features alongside nailfold capillaroscopy findings showing giant capillary loops or dropout abnormalities in 90% of patients.

Blood Tests 

Anti-centromere antibody (ACA) is positive in 60 to 90% of cases and serves as a key prognostic marker for pulmonary hypertension risk. Antinuclear antibody (ANA) is positive in 95% of patients with a speckled pattern. Mild elevation of ESR and CRP may also be present.

Imaging and Other Investigations 

High-resolution CT scan detects lung fibrosis (present in around 40% of cases). Echocardiogram screens for pulmonary hypertension, which develops in 15 to 20% of patients. Esophageal manometry and pH monitoring assess motility dysfunction, abnormal in up to 90% of patients.

Treatment Options

There is no cure for CREST Syndrome. Treatment is symptomatic, organ-protective, and multidisciplinary.

Raynaud's Phenomenon

First-line treatment is calcium channel blockers such as nifedipine (30–120mg daily), effective in around 50% of patients. Losartan, sildenafil, and iloprost infusions are used in resistant cases. Beta-blockers should be avoided as they worsen vasospasm.

Calcinosis

NSAIDs manage pain. Bisphosphonates, colchicine, and IVIG have shown some benefit. Surgical debridement is reserved for severe cases, though recurrence is common (around 50%).

Esophageal Dysfunction

Proton pump inhibitors (PPIs) twice daily are the standard for GERD. Prokinetic agents such as domperidone improve motility. Dietary adjustments, such as smaller meals, avoiding triggers, and elevating the head of the bed, are essential supportive measures.

Sclerodactyly 

Emollients and physiotherapy maintain skin flexibility and hand function. Methotrexate is used in progressive cases. Occupational therapy helps patients adapt to daily activities.

Telangiectasia

Nd:YAG or pulsed dye laser therapy is the most effective option, achieving clearance in around 70% of treated lesions. In cases where telangiectasia appears on mucous membranes, closer monitoring for bleeding is recommended.

Pulmonary Hypertension

The most serious complication. Endothelin receptor antagonists (bosentan, ambrisentan) and PDE-5 inhibitors (sildenafil) are the mainstay. Cyclophosphamide is used when interstitial lung disease is present.

Living With CREST Syndrome

CREST Syndrome is a lifelong condition, but with the right care, most patients live for 30 or more years after diagnosis. Nobody manages CREST syndrome alone. It takes a team, a rheumatologist leading the charge, with a gastroenterologist, pulmonologist, and dermatologist all in the room. And that team needs data. Annual echocardiograms and pulmonary function tests aren't optional; they're how you catch pulmonary hypertension early, which is still the condition's leading killer. But daily habits matter too. Warm extremities, gentle movement, a Mediterranean-style diet, and no smoking. Simple, but real. Around 40% of patients develop anxiety or depression, so psychological support and communities like the Scleroderma Foundation aren't extras. They're part of surviving this long-term.

Final Thought

CREST disease is rare, chronic, and often misunderstood, but it is manageable. The gap between symptom onset and diagnosis can span years, which is why awareness matters. If you notice persistent cold-triggered colour changes in your fingers, unexplained skin tightening, or chronic heartburn alongside any other unusual symptoms, speak to a doctor and ask specifically about autoimmune screening. Caught early, CREST Syndrome can be monitored, treated, and lived with, and for most patients, life expectancy with proper care is reassuringly close to normal. Managing a chronic condition like CREST Syndrome also means planning financially for specialist consultations, regular diagnostics, and long-term medication, which add up over time. NRI Health Insurance and a comprehensive health insurance plan from Niva Bupa ensure that your treatment costs are covered, so you can focus entirely on your health and not your bills. 

Frequently Asked Questions

1. Can CREST Syndrome affect children?

It's vanishingly rare. When scleroderma does appear in younger patients, it almost always shows up as localised scleroderma (morphea) rather than the systemic form. Juvenile systemic sclerosis makes up less than 5% of all scleroderma cases, and CREST specifically is almost always an adult diagnosis.

2. Can pregnancy be affected by CREST Syndrome?

Yes. Pregnancy is a different story. Women with CREST who become pregnant need close monitoring throughout. Raynaud's can worsen during those months, and certain medications commonly used in CREST management some calcium channel blockers and certain immunosuppressants, may need to be adjusted or stopped entirely. That said, most women with CREST can have successful pregnancies. But they shouldn't go through it without a specialist team around them.

3. Is there a connection between CREST Syndrome and cancer?

Research does suggest that people with systemic sclerosis, CREST included, carry a modestly higher risk of certain cancers, particularly lung cancer, non-Hodgkin's lymphoma, and breast cancer. Chronic inflammation and immune dysregulation are thought to be the driving factors here. So regular health screening isn't optional. It's a core part of managing CREST over the long term.

4. Does diet play a role in managing CREST Syndrome?

It won't cause CREST, and it won't cure it. But it genuinely matters for day-to-day symptoms. If esophageal dysfunction is part of your picture, smaller and more frequent meals, cutting back on spicy or acidic foods, and avoiding eating close to bedtime can make a real difference to reflux. A Mediterranean-style diet, with its anti-inflammatory profile, tends to be the general recommendation for disease management and heart health.